Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Emphysema phenotypes and lung cancer risk.

González J, Henschke CI, Yankelevitz DF, Seijo LM, Reeves AP, Yip R, Xie Y, Chung M, Sánchez-Salcedo P, Alcaide AB, Campo A, Bertó J, Del Mar Ocón M, Pueyo J, Bastarrika G, de-Torres JP, Zulueta JJ.

PLoS One. 2019 Jul 25;14(7):e0219187. doi: 10.1371/journal.pone.0219187. eCollection 2019.

2.

Trabecular bone score in active or former smokers with and without COPD.

González J, Rodríguez-Fraile M, Rivera P, Restituto P, Colina I, Calleja MLD, Alcaide AB, Campo A, Bertó J, Seijo LM, Pérez T, Zulueta J, Varo N, de-Torres JP.

PLoS One. 2019 Feb 1;14(2):e0209777. doi: 10.1371/journal.pone.0209777. eCollection 2019.

3.

Pulmonary arterial enlargement predicts long-term survival in COPD patients.

de-Torres JP, Ezponda A, Alcaide AB, Campo A, Berto J, Gonzalez J, Zulueta JJ, Casanova C, Rodriguez-Delgado LE, Celli BR, Bastarrika G.

PLoS One. 2018 Apr 25;13(4):e0195640. doi: 10.1371/journal.pone.0195640. eCollection 2018.

4.

Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients.

Zagaceta J, Bastarrika G, Zulueta JJ, Colina I, Alcaide AB, Campo A, Divo M, Casanova C, Marin JM, Pinto-Plata VM, Celli BR, de-Torres JP.

Respir Res. 2017 Sep 29;18(1):175. doi: 10.1186/s12931-017-0658-y.

5.

Telomere length, COPD and emphysema as risk factors for lung cancer.

de-Torres JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, Pío R, Pajares MJ, Campo A, Berto J, Montuenga L, Del Mar Ocon M, Monente C, Celli BR, Zulueta JJ.

Eur Respir J. 2017 Jan 3;49(1). pii: 1601521. doi: 10.1183/13993003.01521-2016. Print 2017 Jan. No abstract available.

6.

Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation.

Alcaide AB, Sanchez-Salcedo P, Bastarrika G, Campo A, Berto J, Ocon MD, Fernandez-Montero A, Celli BR, Zulueta JJ, de-Torres JP.

Chest. 2017 Feb;151(2):358-365. doi: 10.1016/j.chest.2016.10.044. Epub 2016 Nov 3.

PMID:
27818328
7.

Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.

Garcia-Velloso MJ, Bastarrika G, de-Torres JP, Lozano MD, Sanchez-Salcedo P, Sancho L, Nuñez-Cordoba JM, Campo A, Alcaide AB, Torre W, Richter JA, Zulueta JJ.

Lung Cancer. 2016 Jul;97:81-6. doi: 10.1016/j.lungcan.2016.04.025. Epub 2016 May 2.

PMID:
27237032
8.

The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development.

Sanchez-Salcedo P, de-Torres JP, Martinez-Urbistondo D, Gonzalez-Gutierrez J, Berto J, Campo A, Alcaide AB, Zulueta JJ.

Lung Cancer. 2016 Jul;97:28-34. doi: 10.1016/j.lungcan.2016.04.010. Epub 2016 Apr 16.

PMID:
27237024
9.

COPD comorbidities network.

Divo MJ, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta JJ, Cabrera C, Zagaceta J, Sanchez-Salcedo P, Berto J, Davila RB, Alcaide AB, Cote C, Celli BR; BODE Collaborative Group.

Eur Respir J. 2015 Sep;46(3):640-50. doi: 10.1183/09031936.00171614. Epub 2015 Jul 9.

10.

Improving selection criteria for lung cancer screening. The potential role of emphysema.

Sanchez-Salcedo P, Wilson DO, de-Torres JP, Weissfeld JL, Berto J, Campo A, Alcaide AB, Pueyo J, Bastarrika G, Seijo LM, Pajares MJ, Pio R, Montuenga LM, Zulueta JJ.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):924-31. doi: 10.1164/rccm.201410-1848OC.

11.

Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).

Sanchez-Salcedo P, Berto J, de-Torres JP, Campo A, Alcaide AB, Bastarrika G, Pueyo JC, Villanueva A, Echeveste JI, Lozano MD, García-Velloso MJ, Seijo LM, García J, Torre W, Pajares MJ, Pío R, Montuenga LM, Zulueta JJ.

Arch Bronconeumol. 2015 Apr;51(4):169-76. doi: 10.1016/j.arbres.2014.09.019. Epub 2015 Jan 29. English, Spanish.

12.

Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.

de-Torres JP, Wilson DO, Sanchez-Salcedo P, Weissfeld JL, Berto J, Campo A, Alcaide AB, García-Granero M, Celli BR, Zulueta JJ.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):285-91. doi: 10.1164/rccm.201407-1210OC.

13.

Epicardial adipose tissue in patients with chronic obstructive pulmonary disease.

Zagaceta J, Zulueta JJ, Bastarrika G, Colina I, Alcaide AB, Campo A, Celli BR, de Torres JP.

PLoS One. 2013 Jun 6;8(6):e65593. doi: 10.1371/journal.pone.0065593. Print 2013.

14.

Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1ra.

de-Torres JP, Blanco D, Alcaide AB, Seijo LM, Bastarrika G, Pajares MJ, Muñoz-Barrutia A, Ortiz-de-Solorzano C, Pio R, Campo A, Montes U, Segura V, Pueyo J, Montuenga LM, Zulueta JJ.

PLoS One. 2013;8(4):e60260. doi: 10.1371/journal.pone.0060260. Epub 2013 Apr 5.

15.

Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study.

de-Torres JP, Casanova C, Marín JM, Zagaceta J, Alcaide AB, Seijo LM, Campo A, Carrizo S, Montes U, Cordoba-Lanus E, Baz-Dávila R, Aguirre-Jaime A, Celli BR, Zulueta JJ.

Respir Med. 2013 May;107(5):702-7. doi: 10.1016/j.rmed.2013.01.013. Epub 2013 Mar 7.

16.

FDG Uptake and the Diagnostic Yield of Transbronchial Needle Aspiration.

Seijo LM, Campo A, de Torres JP, Lozano MD, Martino E, Bastarrika G, Alcaide AB, Lacunza M, Zulueta J, Garcia-Velloso MJ.

J Bronchology Interv Pulmonol. 2011 Jan;18(1):7-14. doi: 10.1097/LBR.0b013e318206fc03.

PMID:
23169013
17.

Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD.

de Torres JP, Bastarrika G, Zagaceta J, Sáiz-Mendiguren R, Alcaide AB, Seijo LM, Montes U, Campo A, Zulueta JJ.

Chest. 2011 Jan;139(1):36-42. doi: 10.1378/chest.10-0984. Epub 2010 Aug 12.

PMID:
20705800
18.

Diagnostic yield of electromagnetic navigation bronchoscopy is highly dependent on the presence of a Bronchus sign on CT imaging: results from a prospective study.

Seijo LM, de Torres JP, Lozano MD, Bastarrika G, Alcaide AB, Lacunza MM, Zulueta JJ.

Chest. 2010 Dec;138(6):1316-21. doi: 10.1378/chest.09-2708. Epub 2010 Apr 30.

PMID:
20435658
19.

Low-dose volumetric computed tomography for quantification of emphysema in asymptomatic smokers participating in an early lung cancer detection trial.

Bastarrika G, Wisnivesky JP, Pueyo JC, Díaz L, Arraiza M, Villanueva A, Alcaide AB, Campo A, Seijo L, de Torres JP, Zulueta JJ.

J Thorac Imaging. 2009 Aug;24(3):206-11. doi: 10.1097/RTI.0b013e3181a65263.

PMID:
19704324
20.

Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.

de Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, Seijo LM, Pueyo JC, Villanueva A, Lozano MD, Montes U, Montuenga L, Zulueta JJ.

Chest. 2007 Dec;132(6):1932-8.

21.

Factors determining early adherence to a lung cancer screening protocol.

Montes U, Seijo LM, Campo A, Alcaide AB, Bastarrika G, Zulueta JJ.

Eur Respir J. 2007 Sep;30(3):532-7. Epub 2007 Jun 13.

22.

Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients.

Campo A, Frühbeck G, Zulueta JJ, Iriarte J, Seijo LM, Alcaide AB, Galdiz JB, Salvador J.

Eur Respir J. 2007 Aug;30(2):223-31. Epub 2007 Apr 25.

23.

[Outpatient management of malignant pleural effusion using a tunneled pleural catheter: Preliminary experience].

Seijo L, Campo A, Alcaide AB, Lacunza MM, Armendáriz AC, Zulueta JJ.

Arch Bronconeumol. 2006 Dec;42(12):660-2. Spanish.

24.

Early lung cancer detection using spiral computed tomography and positron emission tomography.

Bastarrika G, García-Velloso MJ, Lozano MD, Montes U, Torre W, Spiteri N, Campo A, Seijo L, Alcaide AB, Pueyo J, Cano D, Vivas I, Cosín O, Domínguez P, Serra P, Richter JA, Montuenga L, Zulueta JJ.

Am J Respir Crit Care Med. 2005 Jun 15;171(12):1378-83. Epub 2005 Mar 24.

PMID:
15790860

Supplemental Content

Loading ...
Support Center